ES423963A1 - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
ES423963A1
ES423963A1 ES423963A ES423963A ES423963A1 ES 423963 A1 ES423963 A1 ES 423963A1 ES 423963 A ES423963 A ES 423963A ES 423963 A ES423963 A ES 423963A ES 423963 A1 ES423963 A1 ES 423963A1
Authority
ES
Spain
Prior art keywords
group
substituted
choice
groups
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES423963A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gist Brocades NV
Original Assignee
Gist Brocades NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades NV filed Critical Gist Brocades NV
Publication of ES423963A1 publication Critical patent/ES423963A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Procedure to prepare derivatives of 6-substituted-aminopenicyllanic and cephalosporanic acids, with the general formulas: **(See formula)** where Q represents the group **(See formula)** where U represents an amido group (eg saccharyl, succinimido or phthalamido) or a group OE' where E' represents hydrogen, a salt-forming cation, a steric residue such as a (lower) alkyl group substituted by choice with a (lower) alkanoyloxy group which can also be substituted, a silyl group, a phenacyl group, a benzyl group, a benzohydryl group, a trichlorethyl group, or tert-butyl group, x represents a hydrogen atom, a hydroxy group , a (lower) alkanoyloxy (preferably acetoxy) group or residue of a nucleophilic agent, such as a halogen atom, an acid group; a cyano group, and carbamoyloxy group, a choice substituted heterocyclic mononuclear group containing a sulfur or nitrogen atom (eg, pyridinyl); an -S-Q' group (where Q' represents a diazolyl, triazolyl, tetrazolyl, thiazolyl, thiadiazolyl, triatriazolyl, oxazolyl, oxadiazolyl, benzimidazolyl, benzoxazolyl, triazol-pyridinyl or puridinyl group), or X represents an amino group where Q represents a group with the formula XX; R1 represents a lower alkyl group (eg methyl, ethyl, propyl, osopropyl, butyl, sec.butyl, isobutyl, t-butyl) optionally substituted in primary or secondary position with 1 fluorine, chlorine atom, a group hydroxy, or lower alkoxy (eg fluoromethyl, 2-chloroethyl, methoxymethyl, 1-hydroxyethyl) or a cycloalkyl group optionally substituted with 1 or more lower alkyl groups, hydroxy or lower alkoxy groups or where R1 represents an adamantyl group or a phenyl group substituted by choice with a maximum of 3 of the substituents selected from chlorine, fluorine, hydroxy, lower alkoxy and lower alkyl, or where R1 represents a five-membered mononuclear heterocyclic group, (for example, furyl, thienyl, isoxazolyl, isothiazolyl, oxadiazolyl) substituted by choice with lower alkyl groups, or where represents an aralkyl group (for example, benzyl) substituted by choice in the phenyl nucleus as mentioned above , ou n carboxymethyl group, and represents, together with the definition indicated above for R1, a hydrogen atom, a (lower) alkyl group optionally substituted with a chlorine or fluorine atom, a (lower) alkoxy group, a cycloalkyl group, a phenyl group, which in turn is substituted by choice with a maximum of three of the aforementioned substituents, or Z1'' represents a carboxy group esterified with a residue of (lower) alkyl, phenyl, cycloalkyl or aralkyl, being at choice said phenyl radicals substituted with a maximum of one of the aforementioned substituents, or represents an N-substituted carbamoyl group of choice with one or two lower alkyl groups, a phenyl group, a five-membered mononuclear heterocyclic group, a cycloalkyl group , one or two arylalkyl (lower) or cycloalkylalkyl (lower) groups, with the phenyl and cycloalkyl groups being substituted with a maximum of one of the substituents a Indicated above, o represents a carbamoyl group having its nitrogen atom as a member of a heterocyclic ring (eg morpholino) and where R2 represents a group **(See formula)** where n represents O, 1, 2 or 3, and R3 represents a hydrogen atom or a lower alkyl group, and R4 represents a hydrogen atom, a lower alkyl, a cycloalkyl, phenyl or aralkyl group, or R4 represents a group -COOE, where E represents a hydrogen atom or a salt-forming group (when n &g; 1), or a residue of (lower) alkyl, benzyl or phenyl ester, or R4 represents a carbamoyl group N- optionally substituted with one or two and (lower) alkyl, or alkenyl groups, a phenyl group, a cycloalkyl group, one or two arialkyl (lower) or cycloalkylalkyl (lower) groups, with the phenyl and cycloalkyl groups being substituted with a maximum of one of the aforementioned substituents, or where R3 and R4, together with the carbon atom to which they are attached, represent a substituted cycloalkyl group of choice, and Z4 represents a hydrogen atom or a substituted aryl group of choice comprising react an acid with the s general formulas: **(See formula)** in which (see graph) are as previously defined for R1 and Z1 or represent groups that can easily become those that fall within the definition of R1 and Z''1 and that can be influenced or can also react under reaction conditions employed (eg protected amino, hydroxy and carboxy groups), or **(See formula)** where (see graph) are as defined above for R2 and Z4 or represent groups that can easily become those that fall within the definition of R2 and Z4 and that can be influenced or react under reaction conditions as well, or **(See formula)** where (see graph) are as previously defined for Z2 and Z3 or represent groups that can easily become those that fall within the definition of Z2 and Z3 and that can also be influenced or react under reaction conditions, with an intermediate phosphazo prepared in situ, obtained by the reaction of phosphorous trichloride and an amine salt or a compound according to the formulas: **(See formula)** in the presence of an exactly predetermined excess of amine used, under anhydrous conditions, followed by separation, isolation or both of the obtained compound and the removal of the protecting groups present at choice in order to form the corresponding free penicillanic or cephalosporic acid, and transform at choice these acids in their salts or esters. (Machine-translation by Google Translate, not legally binding)
ES423963A 1972-12-22 1974-03-06 Heterocyclic compounds Expired ES423963A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5952472A GB1459392A (en) 1972-12-22 1972-12-22 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
ES423963A1 true ES423963A1 (en) 1976-07-01

Family

ID=10483917

Family Applications (3)

Application Number Title Priority Date Filing Date
ES421726A Expired ES421726A1 (en) 1972-12-22 1973-12-21 Heterocyclic compounds
ES423963A Expired ES423963A1 (en) 1972-12-22 1974-03-06 Heterocyclic compounds
ES423962A Expired ES423962A1 (en) 1972-12-22 1974-03-06 Heterocyclic compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES421726A Expired ES421726A1 (en) 1972-12-22 1973-12-21 Heterocyclic compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES423962A Expired ES423962A1 (en) 1972-12-22 1974-03-06 Heterocyclic compounds

Country Status (10)

Country Link
JP (3) JPS4994695A (en)
AT (1) AT344318B (en)
BE (1) BE809037A (en)
DE (2) DE2365705A1 (en)
ES (3) ES421726A1 (en)
FR (2) FR2211232B1 (en)
GB (1) GB1459392A (en)
HU (1) HU167924B (en)
NL (2) NL162654C (en)
SE (3) SE7611134L (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3905893A (en) * 1973-08-22 1975-09-16 Gulf Research Development Co Plural stage residue hydrodesulfurization process

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1364453A (en) * 1970-11-06 1974-08-21 Gist Brocades Nv Penicillanic and cepholosporanic acid derivatives

Also Published As

Publication number Publication date
NL7317432A (en) 1974-06-25
JPS5377088A (en) 1978-07-08
ES421726A1 (en) 1976-04-16
DE2364129A1 (en) 1974-07-25
BE809037A (en) 1974-06-21
FR2289171A1 (en) 1976-05-28
GB1459392A (en) 1976-12-22
NL162654C (en) 1980-06-16
ATA1072573A (en) 1977-11-15
SE7905814L (en) 1979-07-03
SE7611134L (en) 1976-10-07
AT344318B (en) 1978-07-10
ES423962A1 (en) 1976-07-01
NL162654B (en) 1980-01-15
JPS4994695A (en) 1974-09-09
FR2211232A1 (en) 1974-07-19
FR2211232B1 (en) 1978-01-13
NL7807076A (en) 1978-10-31
DE2365705A1 (en) 1976-01-15
JPS5373565A (en) 1978-06-30
SE7611135L (en) 1976-10-07
HU167924B (en) 1976-01-28

Similar Documents

Publication Publication Date Title
DE3363244D1 (en) Compounds, process for their preparation and their use as pharmaceutical preparations
ES8607244A1 (en) Use of quinoline derivatives for the protection of cultivated plants.
NL7505375A (en) NEW PENICILLIN AND CEPHALOSPORIN DERIVATIVES AND METHOD FOR PREPARING THEM.
ATE14579T1 (en) PHARMACEUTICAL HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM.
ES474229A1 (en) New derivatives of 4-phenyl-2-(2',2',2-trichlorethoxycarboxamido)-thiazole useful as medicaments, pharmaceutical compositions containing them and process for the preparation of these compounds.
ES8200685A1 (en) 3-optionally substituted methyl-2- penem derivatives
GB1459065A (en) Therapeutic thiophene derivatives
GB1053085A (en)
GB1505885A (en) Substituted cephalosporins
ES423963A1 (en) Heterocyclic compounds
ES373715A1 (en) Acylation of 6-aminopenicillanic acid and 7-aminocephalosporanic acid
ES8203867A1 (en) Benzothiazole derivatives, pharmaceutical compositions containing them and process for their preparation.
ES479570A1 (en) 7 alpha -Methoxycephalosporin derivatives and their pharmaceutical compositions having antibacterial activity
ES463783A1 (en) Cis-4a-phenyl-2,3,4,4a,5,6,7,7a-octahydro-1h-2-pyrindines and pharmaceutical compositions containing them
IE41219B1 (en) Aralkyl esters of aminoalkanoic acids
ES469182A1 (en) Antibacterial agents
ES270557A1 (en) Procedure for the preparation of new derivatives of the alquilbenzoico acid (Machine-translation by Google Translate, not legally binding)
ES8200372A1 (en) Cephalosporin derivatives and process for their preparation and pharmaceutical compositions containing them.
ES444441A1 (en) A procedure for the preparation of new cephalosporins. (Machine-translation by Google Translate, not legally binding)
ES430905A1 (en) Tetrazole coumarin derivatives
DE2963724D1 (en) Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them
ES483889A1 (en) Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them.
ES227433A3 (en) New procedure for obtaining aminoalkylphenoatiazine. (Machine-translation by Google Translate, not legally binding)
JPS5283679A (en) Pirazine derivative
ES8105325A1 (en) Penicillanic acid derivatives, their preparation and their pharmaceutical compositions with a penicillin or cephalosporin.